P Woodard

Summary

Affiliation: St. Jude Children's Research Hospital
Country: USA

Publications

  1. ncbi request reprint Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome
    Paul Woodard
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
    Pediatr Blood Cancer 47:931-5. 2006
  2. ncbi request reprint Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis
    P Woodard
    Division of Stem Cell Transplantation, Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
    Bone Marrow Transplant 33:1151-7. 2004
  3. ncbi request reprint Effective donor lymphohematopoietic reconstitution after haploidentical CD34+-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia
    P Woodard
    Division of Stem Cell Transplantation, Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
    Bone Marrow Transplant 33:411-8. 2004
  4. ncbi request reprint New approaches to hematopoietic cell transplantation for hematological diseases in children
    Paul Woodard
    Division of Stem Cell Transplantation, St Jude Children s Research Hospital, Memphis, TN, 38105, USA
    Pediatr Clin North Am 49:989-1007. 2002
  5. ncbi request reprint Summary of symposium: the future of stem cell transplantation for sickle cell disease
    Paul Woodard
    Division of Stem Cell Transplantation, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
    J Pediatr Hematol Oncol 24:512-4. 2002
  6. ncbi request reprint Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease
    Paul Woodard
    Department of Hematology Oncology, St Jude Children s Research Hospital, 332 N Lauderdale Street, Lauderdale, Memphis, TN 38105, USA
    Br J Haematol 129:550-2. 2005
  7. ncbi request reprint Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients
    Paul Woodard
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
    J Pediatr Hematol Oncol 25:955-9. 2003
  8. ncbi request reprint Successful unrelated donor bone marrow transplantation for paroxysmal nocturnal hemoglobinuria
    P Woodard
    Division of Bone Marrow Transplantation, Department of Hematology/Oncology, St Jude Children's Research Hospital, Memphis, TN 38105-2794, USA
    Bone Marrow Transplant 27:589-92. 2001
  9. ncbi request reprint Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome
    W Leung
    The Department of Hematology-Oncology, St Jude Children's Research Hospital, 332 N. Lauderdale Street, Memphis, TN 38105, USA
    Bone Marrow Transplant 27:717-22. 2001
  10. ncbi request reprint Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donors
    W H Leung
    Department of Hematology Oncology, Laboratory Medicine and Pathology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
    Hum Immunol 62:399-407. 2001

Detail Information

Publications26

  1. ncbi request reprint Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome
    Paul Woodard
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
    Pediatr Blood Cancer 47:931-5. 2006
    ..Therapy-related myelodysplastic syndrome (t-MDS) and acute myeloid leukemia (t-AML) carry a poor prognosis. We analyzed the results of allogeneic HSCT in 38 children to determine which factors, if any, affected outcome...
  2. ncbi request reprint Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis
    P Woodard
    Division of Stem Cell Transplantation, Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
    Bone Marrow Transplant 33:1151-7. 2004
    ..However, a standardized approach to accurate and timely diagnosis and treatment is needed to improve outcome in these patients...
  3. ncbi request reprint Effective donor lymphohematopoietic reconstitution after haploidentical CD34+-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia
    P Woodard
    Division of Stem Cell Transplantation, Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
    Bone Marrow Transplant 33:411-8. 2004
    ..Further study is required to validate the initial promise of these preliminary observations...
  4. ncbi request reprint New approaches to hematopoietic cell transplantation for hematological diseases in children
    Paul Woodard
    Division of Stem Cell Transplantation, St Jude Children s Research Hospital, Memphis, TN, 38105, USA
    Pediatr Clin North Am 49:989-1007. 2002
    ..This would serve to provide potentially more children who could benefit from stem cell transplantation with donors. These advances will hopefully lead to benefits for the majority of children who lack HLA-identical donors...
  5. ncbi request reprint Summary of symposium: the future of stem cell transplantation for sickle cell disease
    Paul Woodard
    Division of Stem Cell Transplantation, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
    J Pediatr Hematol Oncol 24:512-4. 2002
  6. ncbi request reprint Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease
    Paul Woodard
    Department of Hematology Oncology, St Jude Children s Research Hospital, 332 N Lauderdale Street, Lauderdale, Memphis, TN 38105, USA
    Br J Haematol 129:550-2. 2005
    ..Transient changes occurred early in two patients. Persistent changes occurred in five. Parenchymal lesions occurred in zero of two patients without prior lacunae or infarcts and in all seven with prior lacunae or infarcts (P = 0.0278)...
  7. ncbi request reprint Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients
    Paul Woodard
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
    J Pediatr Hematol Oncol 25:955-9. 2003
    ..To determine the incidence, etiology and outcome of graft failure in pediatric allogeneic bone marrow transplant (BMT) recipients...
  8. ncbi request reprint Successful unrelated donor bone marrow transplantation for paroxysmal nocturnal hemoglobinuria
    P Woodard
    Division of Bone Marrow Transplantation, Department of Hematology/Oncology, St Jude Children's Research Hospital, Memphis, TN 38105-2794, USA
    Bone Marrow Transplant 27:589-92. 2001
    ..T cell-depleted MUD BMT is an effective treatment option for PNH-related MDS and SAA...
  9. ncbi request reprint Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome
    W Leung
    The Department of Hematology-Oncology, St Jude Children's Research Hospital, 332 N. Lauderdale Street, Memphis, TN 38105, USA
    Bone Marrow Transplant 27:717-22. 2001
    ..Immune function 1 year after transplantation and the incidences and spectra of late sequelae were similar for both groups during a median of 3.5 years (range, 1.5 to 7.2 years) of follow-up...
  10. ncbi request reprint Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donors
    W H Leung
    Department of Hematology Oncology, Laboratory Medicine and Pathology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
    Hum Immunol 62:399-407. 2001
    ..Results of this study suggest that disparity in HLA-A and HLA-B antigens may not be better tolerated than disparity in HLA-DR allele in allogeneic BMT. Further studies are warranted to confirm our results...
  11. pmc A novel approach for quantification of KIR expression in healthy donors and pediatric recipients of hematopoietic SCTs
    X Chen
    Department of Oncology, Division of Bone Marrow Transplantation and Cellular Therapy, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
    Bone Marrow Transplant 43:525-32. 2009
    ..Stem cell mobilization caused a transient increase of KIR expression. We conclude that KIR expression differs quantitatively with age and primary disease and is transiently altered by stem cell recruitment and selection...
  12. ncbi request reprint Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome
    G A Hale
    Division of Stem Cell Transplantation, Department of Hematology Oncology, St Jude s Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
    Biol Blood Marrow Transplant 9:698-705. 2003
    ..032), or antithymocyte globulin (P =.0446). Multiple regression analysis revealed male sex (beta =.97; P =.027) and unrelated donor graft recipients (beta =.83; P =.039) to be significant factors...
  13. doi request reprint Total and active rabbit antithymocyte globulin (rATG;Thymoglobulin) pharmacokinetics in pediatric patients undergoing unrelated donor bone marrow transplantation
    Sandra K Call
    Department of Pharmaceutical Services, St Jude Children s Research Hospital, Memphis, Tennessee 38105 3678, USA
    Biol Blood Marrow Transplant 15:274-8. 2009
    ..These conclusions may not apply to patients with nonmalignant disorders...
  14. ncbi request reprint Diagnostic yield of bronchoalveolar lavage is low in allogeneic hematopoietic stem cell recipients receiving immunosuppressive therapy or with acute graft-versus-host disease: the St. Jude experience, 1990-2002
    Kimberly A Kasow
    Division of Bone Marrow Transplantation, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
    Biol Blood Marrow Transplant 13:831-7. 2007
    ....
  15. ncbi request reprint Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients
    Usman Yusuf
    Division of Stem Cell Transplantation, Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
    Transplantation 81:1398-404. 2006
    ..We report our experience with cidofovir (CDV) for treatment of ADV infection in 57 HSCT patients, median age 8 years (range 0.5-26)...
  16. ncbi request reprint EBV lymphoproliferative disease of host origin after haploidentical stem cell transplantation
    Kimberly A Kasow
    Department of Hematology Oncology, Division of Stem Cell Transplantation, St Jude Children s Research Hospital, Memphis, Tennessee 38105 2794, USA
    Pediatr Blood Cancer 49:869-72. 2007
    ..She subsequently developed disseminated PTLPD involving multiple organ and nodal sites. Her neoplastic lymphoblasts were host-derived and refractory to rituximab treatment due to lack of CD20 expression...
  17. pmc Clinical utility of computed tomography screening of chest, abdomen, and sinuses before hematopoietic stem cell transplantation: the St. Jude experience
    Kimberly A Kasow
    Division of Bone Marrow Transplantation and Cellular Therapy, Department of Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
    Biol Blood Marrow Transplant 15:490-5. 2009
    ..The decision to perform chest CT should be made judiciously based on a careful history and physical examination. Sinus imaging, which was frequently abnormal, may be justified in all patients to plan post-HSCT care...
  18. ncbi request reprint Human leucocyte antigen alloimmunization after bone marrow transplantation: an association with chronic myelogenous leukaemia
    Terrence L Geiger
    Department of Pathology, Mail Stop 341, St Jude Children s Research Hospital, 132 North Lauderdale Street, Memphis, TN 38105 2794, USA
    Br J Haematol 117:634-41. 2002
    ..Identifying the mechanism for the increased alloimmunization risk may assist in the development of therapies to prevent platelet refractoriness...
  19. ncbi request reprint T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation
    Eric J Lowe
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN, USA
    Br J Haematol 123:323-6. 2003
    ..In contrast, donor T-cell incompatibility was a risk factor for acute GVHD, chronic GVHD and death. Thus, T-cell alloreactivity dominated that of NK cells in minimally T-cell-depleted grafts...
  20. ncbi request reprint Diagnostic challenge in recurrent skin rash after autologous bone marrow transplantation
    Hiroto Inaba
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
    J Pediatr Hematol Oncol 28:525-8. 2006
    ..Establishment of diagnostic criteria and understanding of the pathophysiology of these entities may lead to better management and to improved therapy of refractory cancer...
  21. ncbi request reprint Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies
    Xiaohua Chen
    Division of Bone Marrow Transplantation, St Jude Children s Research Hospital, Memphis, TN, USA
    Br J Haematol 135:524-32. 2006
    ..Rapid T-cell reconstitution, retention of NK-cells in the graft and induction of low grade GvHD may also enhance the potential anti-cancer immune effect...
  22. ncbi request reprint Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease
    Franco Locatelli
    Oncoematologia Pediatrica, Istituto di Ricovero e Cura a Carattere Scientifico IRCCS Policlinico San Matteo, Universita di Pavia, Italy
    Blood 101:2137-43. 2003
    ..Related CBT for hemoglobinopathies offers a good probability of success and is associated with a low risk of GVHD. Optimization of transplantation strategies could further improve these results...
  23. ncbi request reprint Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome
    Satkiran S Grewal
    Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Genet Med 7:143-6. 2005
    ..However, morbidity and mortality associated with HSCT can limit its success. We describe the initial experience with combined use of enzyme replacement therapy (ERT, laronidase) and HSCT in Hurler syndrome...
  24. ncbi request reprint Re: measurement of chimerism after hematopoietic stem cell transplantation
    Paul Woodard
    Biol Blood Marrow Transplant 8:170. 2002
  25. doi request reprint Changes in outcomes (1996-2004) for pediatric oncology and hematopoietic stem cell transplant patients requiring invasive mechanical ventilation
    Robert F Tamburro
    Penn State Children s Hospital, Pennsylvania State University College of Medicine, Milton S Hersey Medical Center, Hersey, PA, USA
    Pediatr Crit Care Med 9:270-7. 2008
    ....
  26. ncbi request reprint Pulmonary nodular lesions in bone marrow transplant recipients: impact of histologic diagnosis on patient management and prognosis
    H Evin Gulbahce
    Department of Laboratory Medicine and Pathology, University of Minnesota, Fairview University Medical Center, Minneapolis 55455, USA
    Am J Clin Pathol 121:205-10. 2004
    ..Histologic examination is accurate in determining the cause of PNLs and identifying lesions that have a favorable outcome and those that require a change in treatment...